Introduction of a programme for intravascular transfusions at severe rhesus isoimmunization. 1988

M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
Department of Obstetrics and Gynaecology, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.

Thirty-seven fetuses with severe rhesus isoimmunization with a gestational age of less than 30 week underwent 92 intravascular transfusions. Of these, 77 were intracardiac, 13 umbilical vein and two umbilical artery transfusions. Procedure related complications occurred at eight (10%) intracardiac and at two (14%) umbilical cord transfusions. Reversal of hydrops was observed in 10 of 16 fetuses. The perinatal mortality among transfusion treated fetuses was 8/37 (21%). It is concluded that intravascular, intrauterine transfusion leads to improved results among fetuses with early onset of hydrops. Problems concerning indications and technique are discussed.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011295 Prenatal Care Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality. Antenatal Care,Care, Antenatal,Care, Prenatal
D001805 Blood Transfusion, Intrauterine In utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis (ERYTHROBLASTOSIS, FETAL). Fetal Transfusion,Intrauterine Transfusion,Blood Transfusions, Intrauterine,Fetal Transfusions,Intrauterine Blood Transfusion,Intrauterine Blood Transfusions,Intrauterine Transfusions,Transfusion, Fetal,Transfusion, Intrauterine,Transfusion, Intrauterine Blood,Transfusions, Fetal,Transfusions, Intrauterine,Transfusions, Intrauterine Blood
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012203 Rh Isoimmunization The process by which fetal Rh+ erythrocytes enter the circulation of an Rh- mother, causing her to produce IMMUNOGLOBULIN G antibodies, which can cross the placenta and destroy the erythrocytes of Rh+ fetuses. Rh isoimmunization can also be caused by BLOOD TRANSFUSION with mismatched blood. Isoimmunization, Rhesus,Rh Sensitization,Isoimmunization, Rh,Isoimmunizations, Rh,Isoimmunizations, Rhesus,Rh Isoimmunizations,Rh Sensitizations,Rhesus Isoimmunization,Rhesus Isoimmunizations,Sensitization, Rh,Sensitizations, Rh

Related Publications

M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
November 1984, American journal of obstetrics and gynecology,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
December 1992, Revue francaise de gynecologie et d'obstetrique,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
September 1986, American journal of obstetrics and gynecology,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
January 1987, Annales chirurgiae et gynaecologiae. Supplementum,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
November 1987, British journal of obstetrics and gynaecology,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
July 1988, British journal of obstetrics and gynaecology,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
January 2005, Fetal diagnosis and therapy,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
June 1982, LARC medical,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
January 1972, Journal de gynecologie, obstetrique et biologie de la reproduction,
M Westgren, and F Jabbar, and J F Larsen, and F Rahman, and A Selbing, and M Stangenberg
October 1985, Obstetrics and gynecology,
Copied contents to your clipboard!